Please enable JavaScript.
Coggle requires JavaScript to display documents.
DIGITAL-2024-AI-06-IMAGING - AI in support Metabolic Magnetic Resonance…
DIGITAL-2024-AI-06-IMAGING - AI in support Metabolic Magnetic Resonance Imaging Systems of Quantum-Enhanced
SME Support Actions — 50% and 75%
Scope
To develop and experimentally validate in an hospital environment a more precise and faster tool for the study, diagnosis, treatment and follow-up of cancer and/or neurological disorders (such as Alzheimer’s disease and multiple sclerosis) by enhancing existing MRI systems with quantum- enhanced metabolic MRI and AI techniques.
Phase 1
(Pre-clinical)
-
Creation of an initial experimental AI
model to analyse the MRI images in combination
with inputs from other sources
Phase 2
(Clinical)
Deployment and validation in a clinical environment of two second-generation polariser systems and associated AI techniques (tumour growth and disease progression, diagnosis, treatment selection and decision-making, optimise treatment of cancer and/or neurological diseases.)
Objectives
Faster, more accurate and personalized diagnosis, treatment and follow-up notably of cancer and/or neurological disorders.
Industrialisation and deployment of such emerging systems, with a focus on cancer imaging and/or neurological imaging.
Deliverables
-
-
-
-
-
-
-
Extended AI models as a tool for diagnosis, treatment selection and decision-making
KPI
-
-
-
-
-
-
-
-
-
Number of AI models developed, tested and validated
Number of activities organised for collaboration,